23andMe Wants Researchers to Use Its Kits, in a Bid to Expand Its Collection of Genetic Data
July 14, 2016
(The Verge) – 23andMe, the direct-to-consumers genetics company, is launching a new service that allows researchers to use 23andMe’s saliva collection kit and genotyping services for their own genetic research studies. In return, research participants can decide to enroll in the 23andMe database and receive information about their genetic makeup. The service benefits 23andMe both in terms of new revenue (the company will charge $199 per DNA sample), as well as new patients’ genetic data that will be included in the 23andMe database, if patients agree to it. That means that, if patients give their consent, this anonymous aggregated genetic data can be sold by 23andMe to other researchers and pharmaceutical companies for other research purposes.